For the year ending 2025-12-31, CVS made $402,067M in revenue. $1,768M in net income. Net profit margin of 0.44%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total revenues | 402,067 | 372,809 | 357,776 | 322,467 |
| Cost of products sold | 221,167 | 206,287 | 217,098 | 196,892 |
| Health care costs | 125,538 | 115,121 | - | - |
| Store impairments | - | - | 0 | 0 |
| Operating expenses | 44,977 | 41,606 | 39,832 | - |
| Health care costs | - | - | 86,247 | 71,281 |
| Goodwill impairment | 5,725 | - | 0 | 0 |
| Restructuring charges | 0 | 1,179 | 507 | - |
| Opioid litigation charges | - | -100 | 0 | -5,803 |
| Operating expenses | - | - | - | 38,212 |
| Loss on assets held for sale | 0 | 0 | 349 | 2,533 |
| Total operating costs | 397,407 | 364,293 | 344,033 | 314,721 |
| Operating income | 4,660 | 8,516 | 13,743 | 7,746 |
| Interest expense | 3,119 | 2,958 | 2,658 | 2,287 |
| Gain on early extinguishment of debt | 0 | 491 | 0 | 0 |
| Gain on deconsolidation of subsidiary | 483 | - | - | - |
| Other income | 112 | 99 | 88 | 169 |
| Income before income tax provision | 2,136 | 6,148 | 11,173 | 5,628 |
| Income tax provision | 408 | 1,562 | 2,805 | 1,463 |
| Income from continuing operations | - | - | - | 4,165 |
| Loss from discontinued operations, net of tax | - | - | - | 0 |
| Net income | 1,728 | 4,586 | 8,368 | 4,165 |
| Net (income) loss attributable to noncontrolling interests | -40 | -28 | 24 | 16 |
| Net income attributable to cvs health | 1,768 | 4,614 | 8,344 | 4,149 |
| Basic (in dollars per share) | 1.4 | 3.67 | 6.49 | 3.16 |
| Basic (in shares) | 1,267,000,000 | 1,259,000,000 | 1,285,000,000 | 1,312,000,000 |
| Diluted (in dollars per share) | 1.39 | 3.66 | 6.47 | 3.14 |
| Diluted (in shares) | 1,271,000,000 | 1,262,000,000 | 1,290,000,000 | 1,323,000,000 |
CVS HEALTH Corp (CVS)
CVS HEALTH Corp (CVS)